Last update 02 May 2026

FB-7013

Overview

Basic Info

Drug Type
siRNA
Synonyms
FB 7013, FB7013
Target
MASP2
Action
inhibitors
Mechanism
MASP2 inhibitors(Mannan-binding lectin serine protease 2 inhibitors)
Therapeutic Areas
Immune System DiseasesUrogenital Diseases
Active Indication
Glomerulonephritis, IGA
Inactive Indication-
Originator Organization
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
Active Organization
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
Inactive Organization-
License Organization
GSK PlcGSK PlcFrontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

1
Clinical Trials associated with FB-7013
CTR20261560
/ Not yet recruitingPhase 1
在健康参与者中开展的随机、双盲、安慰剂对照，评估FB7013注射液不同剂量单次及多次给药的安全性、耐受性和药代动力学的Ⅰ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase I clinical trial in healthy participants to evaluate the safety, tolerability, and pharmacokinetics of different single and multiple doses of FB7013 injection.
100 Clinical Results associated with FB-7013
Login to view more data
100 Translational Medicine associated with FB-7013
Login to view more data
100 Patents (Medical) associated with FB-7013
Login to view more data
100 Deals associated with FB-7013
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glomerulonephritis, IGAPhase 1
China
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
29 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free